Vimarsana
Biggest News Aggregation in the World

Page 35 - Jonathan Watts News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Watts. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Watts Today - Breaking & Trending Today

Watsons expands into GCC with new stores - Vimarsana News

Watsons expands into GCC with new stores

Asian health and beauty retailer Watsons is fast expanding across the GCC as it recently opened its first store in Qatar at Doha Festival City. This follows the retailer’s recent entry into other regional markets, namely Saudi Arabia and the UAE. In addition to the new Qatar store, Watsons now has stores in Mall of Dhahran in the Kingdom, and Dubai Mall, Dubai Festival City,

Burning Up | Asia Society - Vimarsana News

Burning Up | Asia Society

In this first episode of the COAL+ICE podcast, top climate journalists talk about what these choices look like in China, South Africa and Brazil and what's being done, and needs to be done, to bend the curve on climate change.

European Union (EU) Parliament, Schema-Root news - Vimarsana News

European Union (EU) Parliament, Schema-Root news

Cross-linked news, and information resources about European Union (EU) Parliament

UMass Chan trial first to demonstrate breakthrough ALS treatment in human - Vimarsana News

UMass Chan trial first to demonstrate breakthrough ALS treatment in human

A clinical trial for ALS research led by two UMass Chan Medical School doctors has shown significant progress in suppressing the most commonly mutated ALS gene, according to an announcement from the Angel Fund for ALS Research.

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene - Vimarsana News

Single-patient pilot study shows the ability of antisense oligonucleotide to suppress mutant ALS gene

Using a short, synthetic chain of chemically modified nucleotides engineered in the RNA Therapeutics Institute at UMass Chan Medical School, Robert H. Brown Jr., DPhil, MD, Jonathan Watts, PhD, and colleagues have shown the ability to suppress mutant forms of an ALS gene known as C9ORF72 in a single-patient pilot study.